Literature DB >> 33160725

Standardized results of the Montreal Cognitive Assessment (MoCA) for neurocognitive screening in a Chilean population.

M Gaete1, S Jorquera2, S Bello-Lepe3, Y M Mendoza4, M Véliz2, M F Alonso-Sanchez3, J Lira5.   

Abstract

INTRODUCTION: Population ageing poses a challenge for countries in preventing and detecting neurodegenerative disorders. The Montreal Cognitive Assessment (MoCA), a short, simple, valid, and reliable screening test, assesses general cognitive status, and is useful in public health contexts. This study aims to normalise and standardise the MoCA test for the Chilean population.
METHOD: We performed a descriptive, correlational validation study of the MoCA test, using a sample including 526 healthy individuals of both sexes, aged between 18 and 90 years, from the north, centre, and south of Chile. We analysed the effects of age, education level, and sex on MoCA performance.
RESULTS: Age and education level had a significant impact on general cognitive performance, as determined by MoCA score. Age, education, and sex account for 1-7% of variance. The mean (standard deviation) score for the total sample was 24.04 (3.22), whereas the normal range originally defined for the instrument is 26-30 points. Older adults with less formal education presented poorer results and lower cognitive performance. We propose a protocol for evaluating results by percentiles and scores for different age ranges, and an individual normalised scalar score. DISCUSSION: We present normative data for the MoCA test in the Chilean population, and propose cut-off points for different age ranges to discriminate normal cognitive performance from neurocognitive disorders; results are adjusted for education level. This proposal would assist in the use of the test and reduce the rate of false positives.
Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Cognitive screening; Cribado cognitivo; Enfermedad neurodegenerativa; Evaluación neuropsicológica; Montreal Cognitive Assessment; Neurodegenerative disease; Neuropsychological evaluation

Year:  2020        PMID: 33160725     DOI: 10.1016/j.nrl.2020.08.017

Source DB:  PubMed          Journal:  Neurologia (Engl Ed)        ISSN: 2173-5808


  3 in total

1.  Causes of symptom dissatisfaction in patients with generalized myasthenia gravis.

Authors:  Linda Kahr Andersen; Anna Sofie Jakobsson; Karoline Lolk Revsbech; John Vissing
Journal:  J Neurol       Date:  2021-11-21       Impact factor: 4.849

2.  Value of Magnetic Resonance Diffusion Tensor Imaging Combined with Quantitative Electroencephalogram in Diagnosis of Neurocognitive Impairment in Patients with White Matter Demyelination.

Authors:  Jun Li; Hongtao Li; Yun Ma; Xiaowei Cai; Yinjie Zhong; Chunjie Song
Journal:  Contrast Media Mol Imaging       Date:  2021-08-03       Impact factor: 3.161

3.  Regression-Based Normative Data for the Montreal Cognitive Assessment (MoCA) and Its Memory Index Score (MoCA-MIS) for Individuals Aged 18-91.

Authors:  Roy P C Kessels; Nathalie R de Vent; Carolien J W H Bruijnen; Michelle G Jansen; Jos F M de Jonghe; Boukje A G Dijkstra; Joukje M Oosterman
Journal:  J Clin Med       Date:  2022-07-13       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.